Neurovascular Thrombectomy Devices Market Revenue to Attain USD 1,399.05 Mn by 2033

Published: 14 Nov 2025

Author: Precedence Research

Share :

Table of Content

1. Neurovascular Thrombectomy Devices Market Revenue and Trends 2025 to 2033 2. Why is this market growing drastically? 3. Segment Insights 4. Regional Insights 5. Neurovascular Thrombectomy Devices Market Coverage

Neurovascular Thrombectomy Devices Market Revenue and Trends 2025 to 2033

The global neurovascular thrombectomy devices market revenue surpassed USD 825.92 million in 2025 and is predicted to attain around USD 1,399.05 million by 2033, growing at a CAGR of 6.81%. This market is growing due to the rising incidence of large-vessel ischemic stroke, expanding stroke-care networks, stronger clinical evidence for mechanical thrombectomy, and increased capital investment in advanced neuro-intervention tools, all of which are driving demand for thrombectomy devices.

Why is this market growing drastically?

The first factor is the global burden of ischemic stroke and recognition of large-vessel occlusions (LVOs), requesting clearly definitive mechanical treatment options. The second factor is that positive randomized trials for thrombectomy, as well as registry studies showing a significant functional benefit, have changed clinical guidelines and expanded treatment windows for the intervention, driving acceptance of thrombectomy in hospitals and procedural throughput. Third, the technology, with better stent retriever shapes, better aspiration catheter systems, better systems combining techniques, and better delivery wires that take the user into consideration, has improved first-pass success and safety profile and has pushed user preference in favour of thrombectomy. Fourth, increased financial equity for comprehensive stroke centers, expanded EMS triage and transfer systems, and better reimbursements have facilitated capital expenditures for neurointerventional suites. And the last factor is competition in establishing medtech companies and new entrants create increases in launches, price competition, and bundles of services.

Segment Insights

• By Product Type, the stent retrievers segment dominated the market in2024, as their proven recanalization rates, clinician comfort and familiarity, a wide range of indications for large vessel occlusions, and a large evidence base regarding outcomes and usage in availability across major device manufacturers and healthcare facilities around the globe and consistently.
• By Usability, reusable devices dominate the market share, because the use of reusable devices lowers per-procedure costs, ties in with sustainability goals, facilitates rapid clinician-learning curves, means there is more performance across cases, and are often used in high-volume stroke centers looking to improve patient files and improve supply chain and comfort for a consistent workflow.
• By Application, ischemic stroke is the dominating segment of the market because mechanical thrombectomy has become the gold standard for managing patients with large vessel occlusions, and has driven a proliferation of devices, increased volume of cases, clinical research, and reimbursement of early intervention and better outcomes for people with a stroke era.
• By End-User, the hospital segment dominates the market because they have full, comprehensive stroke teams and capabilities for advanced imaging, a neurosurgical theatre, and an interventional neuroradiology suite, to create a multidisciplinary approach for patient care.

Regional Insights

The North America region leads the market due to established stroke networks, higher rate of procedures, solid reimbursements, and fast adoption of neurointerventional technologies. Hospitals and academic centers are heavily investing into dedicated stroke suites with nursing education that allows them to maintain leadership in device adoption and clinical studies.

Asia-Pacific is the fastest-growing region due to governments expanding healthcare access, increasing stroke awareness, and investing in tiered tertiary care infrastructure. There are increasing numbers of stroke centers, favourable reimbursement changes in a number of countries, and vigorous commercial activity of global and local device makers that is spurring growth across the region.

Neurovascular Thrombectomy Devices Market Coverage

Recent Developments

• In June 2025, Terumo Neuro introduced the SOFIA Flow 88 Aspiration Catheter, expanding its neurovascular portfolio. The device offers superior trackability and flexibility, providing clinicians with improved control and performance during mechanical thrombectomy procedures. (Source: https://neuronewsinternational.com)

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7098

You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344